Western blot analyses showed that ARQ 092 and the combination of ARQ 092 with sorafenib treatment blocked phosphorylation of AKT(Ser473) in all human HCC cell lines at both IC20 and IC50 concentrations (Supplementary Figure 5). Here, AKT1 is linked to hepatocellular carcinoma.